AffirmedRx doesn’t operate like other pharmacy benefit managers, and that’s the point.
While most PBMs profit from rebates, spread pricing and data brokering, this Louisville-based firm runs on a flat administrative fee. Rebates flow directly to clients. The data belongs to the employer groups and the incentive to inflate costs never existed.
“We simplify the complexities of filling prescriptions so patients can confidently access the best care to get and stay healthy,” the company spokesperson states.
Founded in 2021 as EmsanaRx under the Emsana Health group of companies, the organization rebranded to AffirmedRx in 2023. The name draws from Affirmed, the legendary racehorse who won the Kentucky Derby and the Triple Crown in 1978. It’s a fitting metaphor for a company positioning itself as an industry challenger, with roots in Louisville, KY.
What makes AffirmedRx unusual isn’t just its pricing structure; it’s the legal framework.
The company operates as a Public Benefit Corporation, a designation that requires balancing shareholder returns with broader stakeholder interests.
That doesn’t exist in an industry where conflicts of interest run deep. Traditional PBMs negotiate rebates with pharmaceutical manufacturers, but those rebates often don’t translate into lower costs for patients. Data generated from prescription claims gets monetized and formularies, the lists of covered drugs, can favor medications that generate higher rebates over equally effective alternatives.
AffirmedRx rejects those practices entirely. The company negotiates prices with pharmaceutical manufacturers and maintains a network of over 67,000 retail pharmacies. It creates formularies based on clinical appropriateness rather than financial incentives. 100% of rebates earned from branded medications go directly to employer groups. Pricing is pass-through, meaning clients see exactly where every dollar goes.
The company also provides what it calls “radical data transparency.” Employers get complete access to their pharmacy benefit data, which most PBMs guard like state secrets. That access allows clients to analyze spending patterns, identify cost-saving opportunities, and verify that the PBM isn’t profiting from hidden fees.
But transparency alone doesn’t solve the patient experience problem.
That’s where the Patient Care Advocate model comes in.
Patient Care Advocates Guide Members Through Complexities
AffirmedRx introduced its first Patient Care Advocacy Program in 2022. These advocates work directly with members to resolve prior authorizations, navigate coverage issues, and find lower-cost alternatives.
The approach contrasts sharply with traditional PBM customer service. Call centers. Long wait times. Scripted responses. Patient Care Advocates at AffirmedRx function more like case managers, taking ownership of individual members’ needs and following through until issues are finally resolved.
These interventions require time, competence, and a business model that doesn’t penalize cost reduction. AffirmedRx can afford to pursue them because it doesn’t profit when drug spending increases. The flat administrative fee remains the same whether members fill expensive prescriptions or find cheaper alternatives.
When AffirmedRx reviews individual cases with its Patient Care Advocates, the focus stays on clinical appropriateness and member support. That matters in an industry where financial incentives often conflict with patient outcomes.
The company received URAC accreditation, joining a small group of PBMs that meet those industry standards for quality and accountability. URAC accreditation requires demonstrating competency in areas like formulary management, utilization management, clinical services and consumer protection.
Public Benefit Corporation Structure Protects Mission
The Public Benefit Corporation designation isn’t just branding. It’s a legal commitment that survives capital raises, leadership changes and acquisition offers.
Unlike traditional corporations, which must prioritize shareholder value above all else, PBCs are required to consider the impact of their decisions on all stakeholders: employees, customers, communities, and the environment.
For AffirmedRx, that means company leaders can make decisions that benefit patients even when those choices reduce short-term profitability. It also means the company must report annually on its public benefit performance, creating accountability beyond financial metrics.
Three other organizations have spun out from AffirmedRx, all addressing different aspects of pharmacy benefit challenges. TransparencyRx operates as a nonprofit advocacy platform for next-generation PBMs. JustifyRx functions as a rebate aggregator, also structured as a Public Benefit Corporation. Bowtie Therapeutics is a healthcare benefit provider that focuses on cell and gene therapy benefits.
The creation of these entities suggests a broader effort to reshape the pharmacy benefits industry rather than only offer a transparent alternative PBM option. Whether that effort gains traction depends on whether employer groups and health plans are willing to abandon incumbent vendors with established relationships.
AffirmedRx believes the market is ready for a change. The company points to growing frustration with traditional PBMs, increased regulatory scrutiny and rising awareness of pricing practices that inflate costs without improving outcomes. Employers are asking harder questions about where their pharmacy benefit dollars go. They’re demanding answers that shouldn’t require forensic accounting to decipher.
Culture of Stewardship Reinforces Member-First Approach
AffirmedRx calls its employees “Stewards”, a term borrowed from the Kentucky Derby. At the Derby, stewards ensure fair play and uphold the integrity of the race. They monitor every detail, enforce rules, and maintain standards.
The company applies that concept to its workforce. Stewards at AffirmedRx are responsible for upholding values, delivering service with integrity and guiding the organization toward its mission. It’s a deliberate cultural choice meant to reinforce the idea that employees aren’t just processing claims or managing contracts. They’re safeguarding something larger.
AffirmedRx operates on ten core values, represented by the acronym HEART squared. Honest. Humble. Ethical. Empathetic. Authentic. Accountable. Respectful. Responsible. Tenacious. Transparent. The company states that these values guide all business practices and decision-making.
The emphasis on values-driven operations isn’t unique to AffirmedRx but the Public Benefit Corporation structure makes those values legally enforceable. The board can’t abandon them without violating the company’s charter. That creates a different kind of accountability than corporate mission statements typically carry.
Industry Challenges Demand Structural Solutions
The pharmacy benefit management industry faces mounting criticism from multiple directions.
AffirmedRx argues that incremental reforms won’t fix systemic problems. The company believes the industry needs structural change, starting with business models that don’t profit from higher drug costs. That’s why it rejects what it calls “transparent models.” PBMs that market transparency but retain backend revenue streams.
The company partners with organizations that share its approach. It also leverages technology to improve service delivery and member experience. A mobile app partner uses AI-powered tools to provide savings opportunities and health insights. The Pharmacy and Therapeutic Committee, a body of medical professionals, meets regularly to develop clinically appropriate formularies that control costs without compromising patient care.
The challenge isn’t just operational. It’s cultural.
The company has to prove that a PBM can succeed financially while rejecting the revenue streams that make traditional PBMs profitable. That requires convincing clients to pay a transparent administrative fee instead of relying on hidden rebates and spread pricing that obscure true costs. It requires demonstrating that Patient Care Advocates deliver measurable value, not just better member satisfaction scores and it requires sustained commitment to a Public Benefit Corporation structure that prioritizes long-term mission over short-term returns.
AffirmedRx is betting that a growing number of employers and health plans are willing to trade those advantages for a model that aligns incentives, reduces complexity and puts patients first.
The pharmacy benefit management industry has operated the same way for decades. AffirmedRx is testing whether a different approach can work. The answer will determine whether transparency and patient advocacy can compete with rebates and spread pricing, or whether the economics of the industry make structural change impossible.
Source: https://spacecoastdaily.com/2026/03/affirmedrx-challenges-pbm-status-quo-with-transparency-model/